Unlocking Alzheimer’s Plaque Clearance: VIB and KU Leuven Scientists Reveal Crucial Role of Antibody’s Fc Fragment in Microglial Activation
A groundbreaking study by scientists at the VIB and KU Leuven has precisely delineated the mechanism by which lecanemab, marketed as Leqembi, a monoclonal antibody treatment for Alzheimer’s disease, effectively…







